DE60202662D1 - NEUE FILMBESCHICHTUNG enthaltend ein Äthylacrylate/Methylmethacrylate-copolymer und Polyvinylacetat - Google Patents

NEUE FILMBESCHICHTUNG enthaltend ein Äthylacrylate/Methylmethacrylate-copolymer und Polyvinylacetat

Info

Publication number
DE60202662D1
DE60202662D1 DE60202662T DE60202662T DE60202662D1 DE 60202662 D1 DE60202662 D1 DE 60202662D1 DE 60202662 T DE60202662 T DE 60202662T DE 60202662 T DE60202662 T DE 60202662T DE 60202662 D1 DE60202662 D1 DE 60202662D1
Authority
DE
Germany
Prior art keywords
film coating
methyl methacrylate
ethyl acrylate
polyvinyl acetate
methacrylate copolymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60202662T
Other languages
English (en)
Other versions
DE60202662T2 (de
Inventor
Johan Hjartstam
Jan-Erik Lofroth
Staffan Schantz
Anders Welin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0104328A external-priority patent/SE0104328D0/xx
Priority claimed from SE0104327A external-priority patent/SE0104327D0/xx
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE60202662D1 publication Critical patent/DE60202662D1/de
Application granted granted Critical
Publication of DE60202662T2 publication Critical patent/DE60202662T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Surface Treatment Of Glass Fibres Or Filaments (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Piezo-Electric Transducers For Audible Bands (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60202662T 2001-12-19 2002-12-18 NEUE FILMBESCHICHTUNG enthaltend ein Äthylacrylate/Methylmethacrylate-copolymer und Polyvinylacetat Expired - Lifetime DE60202662T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0104328A SE0104328D0 (sv) 2001-12-19 2001-12-19 New film coating
SE0104327 2001-12-19
SE0104328 2001-12-19
SE0104327A SE0104327D0 (sv) 2001-12-19 2001-12-19 New film coating
PCT/GB2002/005739 WO2003051340A1 (en) 2001-12-19 2002-12-18 New film coating

Publications (2)

Publication Number Publication Date
DE60202662D1 true DE60202662D1 (de) 2005-02-24
DE60202662T2 DE60202662T2 (de) 2006-01-05

Family

ID=26655630

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60202662T Expired - Lifetime DE60202662T2 (de) 2001-12-19 2002-12-18 NEUE FILMBESCHICHTUNG enthaltend ein Äthylacrylate/Methylmethacrylate-copolymer und Polyvinylacetat
DE20220902U Expired - Lifetime DE20220902U1 (de) 2001-12-19 2002-12-18 Neuer Filmüberzug

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE20220902U Expired - Lifetime DE20220902U1 (de) 2001-12-19 2002-12-18 Neuer Filmüberzug

Country Status (26)

Country Link
US (2) US6827947B2 (de)
EP (2) EP1477163A1 (de)
JP (1) JP2005514386A (de)
KR (1) KR20040065989A (de)
CN (1) CN100341491C (de)
AT (1) ATE287259T1 (de)
AU (2) AU2002361447B2 (de)
BR (1) BR0206441A (de)
CA (1) CA2435729C (de)
CZ (1) CZ20031970A3 (de)
DE (2) DE60202662T2 (de)
DK (1) DK1355633T3 (de)
ES (1) ES2233876T3 (de)
HK (1) HK1058312A1 (de)
HU (1) HUP0303886A3 (de)
IL (1) IL156998A0 (de)
IS (1) IS6863A (de)
MX (1) MXPA03007156A (de)
NO (1) NO320358B1 (de)
NZ (1) NZ526926A (de)
PL (1) PL362378A1 (de)
PT (1) PT1355633E (de)
RU (1) RU2323717C2 (de)
SI (1) SI1355633T1 (de)
SK (1) SK9132003A3 (de)
WO (1) WO2003051340A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
DE60202662T2 (de) * 2001-12-19 2006-01-05 Astrazeneca Ab NEUE FILMBESCHICHTUNG enthaltend ein Äthylacrylate/Methylmethacrylate-copolymer und Polyvinylacetat
MXPA04008100A (es) 2002-02-21 2005-06-17 Biovail Lab Int Srl Formulaciones de liberacion modificada de al menos una forma de tramadol.
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating
US7080545B2 (en) * 2002-10-17 2006-07-25 Advanced Technology Materials, Inc. Apparatus and process for sensing fluoro species in semiconductor processing systems
NZ547284A (en) * 2003-10-31 2009-12-24 Hexal Ag Pharmaceutical agent-containing formulation comprising a coating of a film forming polymer
WO2005084636A2 (en) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited A process for the preparation of controlled-release pharmaceutical composition of metoprolol
JP2005306778A (ja) * 2004-04-21 2005-11-04 Basf Ag 徐放性製剤及びその製造方法
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
DE102004035936A1 (de) * 2004-07-23 2006-03-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
AU2006275718B8 (en) * 2005-07-28 2012-11-01 Takeda Pharmaceutical Company Limited Pharmaceutical formulations/composition of guanfacine suitable for single dose form adminstration daily
JP5259413B2 (ja) * 2005-11-18 2013-08-07 エーシーシーユー−ブレイク テクノロジーズ，インク． セグメント化した薬の剤形
DE102005060393A1 (de) 2005-12-16 2007-06-21 Add Advanced Drug Delivery Technologies Ltd. Orales Präparat mit kontrollierter Freisetzung
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
TW201117812A (en) 2009-08-05 2011-06-01 Idenix Pharmaceuticals Inc Macrocyclic serine protease inhibitors
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
RU2554087C2 (ru) 2009-12-18 2015-06-27 Айденикс Фармасьютикалз, Инк. 5,5-конденсированные ариленовые или гетероариленовые ингибиторы вируса гепатита с
IL210279A0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011112689A2 (en) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Saltz of an indazolylpyrrolotriazine
AU2011296046B2 (en) 2010-09-01 2015-05-14 Ambit Biosciences Corporation Hydrobromide salts of a pyrazolylaminoquinazoline
ES2581840T3 (es) 2010-09-01 2016-09-07 Ambit Biosciences Corporation Pirazolilaminoquinazolina ópticamente activa y composiciones farmacéuticas y métodos de uso de la misma
WO2012078649A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
CA2825152A1 (en) 2011-01-31 2012-08-09 Celgene Corporation Pharmaceutical compositions of cytidine analogs and methods of use thereof
AR085352A1 (es) 2011-02-10 2013-09-25 Idenix Pharmaceuticals Inc Inhibidores macrociclicos de serina proteasa, sus composiciones farmaceuticas y su uso para tratar infecciones por hcv
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
MX356579B (es) * 2011-06-17 2018-06-05 Evonik Roehm Gmbh Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol.
MX353427B (es) * 2011-06-17 2018-01-12 Evonik Roehm Gmbh Composicion de recubrimiento adecuada para formas de dosis farmaceuticas o nutraceuticas.
EP2852586A1 (de) 2012-03-16 2015-04-01 Axikin Pharmaceuticals, Inc. 3,5-diaminopyrazol-kinaseinhibitoren
BR112015018895A2 (pt) 2013-02-13 2017-07-18 Evonik Roehm Gmbh composição farmacêutica multiparticulada compreendendo uma multiplicidade de dois tipos de pelotas
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
EP3046924A1 (de) 2013-09-20 2016-07-27 IDENIX Pharmaceuticals, Inc. Inhibitoren des hepatitis-c-virus
JP5846185B2 (ja) 2013-11-21 2016-01-20 大日本印刷株式会社 貫通電極基板及び貫通電極基板を用いた半導体装置
WO2015134560A1 (en) 2014-03-05 2015-09-11 Idenix Pharmaceuticals, Inc. Solid forms of a flaviviridae virus inhibitor compound and salts thereof
MX2016012097A (es) 2014-03-20 2017-04-27 Capella Therapeutics Inc Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cáncer.
US10202398B2 (en) 2014-03-20 2019-02-12 Capella Therapeutics, Inc. Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer
MX2017000384A (es) * 2014-07-09 2017-04-27 Sun Pharmaceutical Ind Ltd Forma de dosificacion en capsulas de succinato de metoprolol.
WO2016042565A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release 'formulation of metoprolol
MY191736A (en) 2014-12-23 2022-07-13 Axikin Pharmaceuticals Inc 3,5-diaminopyrazole kinase inhibitors
MX2019000213A (es) * 2016-06-30 2019-05-13 Beckman Coulter Inc Sustratos quimiluminiscentes.
WO2019183470A2 (en) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. A novel method to slow ventricular rate

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB878234A (en) 1958-12-18 1961-09-27 Roehm & Haas Gmbh Pharmaceutical coating compositions
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3341338A (en) * 1965-05-28 1967-09-12 Union Carbide Corp Polysiloxane polish formulations
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4916171A (en) * 1984-07-25 1990-04-10 Rohm And Haas Company Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US5246714A (en) * 1985-10-11 1993-09-21 Aktiebolaget Hassle Drug preparation
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US4975283A (en) * 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US4871546A (en) * 1987-06-29 1989-10-03 Sandoz Pharm. Corp. Gastrointestinal protective coating formulations
JP2782691B2 (ja) * 1987-09-29 1998-08-06 ワーナー−ランバート・コンパニー 腸溶製剤の安定化
US5292522A (en) * 1989-06-20 1994-03-08 Rohm Gmbh Aqueous film coating agent for solid medicaments
FR2655266B1 (fr) 1989-12-05 1992-04-03 Smith Kline French Lab Compositions pharmaceutiques a base de cimetidine.
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
ATE195252T1 (de) * 1993-04-23 2000-08-15 Novartis Erfind Verwalt Gmbh Wirkstoffabgabevorrichtung mit gesteuerter freigabe
CA2117546A1 (en) * 1993-08-27 1995-02-28 Takateru Muraoka Medical adhesive sheet
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
DE60202662T2 (de) * 2001-12-19 2006-01-05 Astrazeneca Ab NEUE FILMBESCHICHTUNG enthaltend ein Äthylacrylate/Methylmethacrylate-copolymer und Polyvinylacetat
US20030175342A1 (en) * 2002-03-14 2003-09-18 Karl Kolter Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) 2002-08-01 2002-08-01 Astrazeneca Ab New film coating

Also Published As

Publication number Publication date
RU2003125371A (ru) 2005-02-10
EP1355633B1 (de) 2005-01-19
CN100341491C (zh) 2007-10-10
MXPA03007156A (es) 2003-11-18
AU2008207594A1 (en) 2008-09-18
DE20220902U1 (de) 2004-06-09
NO320358B1 (no) 2005-11-28
WO2003051340A1 (en) 2003-06-26
NO20033653D0 (no) 2003-08-18
PT1355633E (pt) 2005-05-31
SI1355633T1 (en) 2005-06-30
CZ20031970A3 (cs) 2003-10-15
AU2002361447A1 (en) 2003-06-30
PL362378A1 (en) 2004-10-18
BR0206441A (pt) 2003-12-30
US20050089574A1 (en) 2005-04-28
RU2323717C2 (ru) 2008-05-10
KR20040065989A (ko) 2004-07-23
US7815938B2 (en) 2010-10-19
US20040030033A1 (en) 2004-02-12
AU2002361447B2 (en) 2008-05-29
SK9132003A3 (en) 2004-02-03
EP1477163A1 (de) 2004-11-17
HUP0303886A2 (hu) 2004-05-28
ATE287259T1 (de) 2005-02-15
IS6863A (is) 2003-07-01
IL156998A0 (en) 2004-02-08
JP2005514386A (ja) 2005-05-19
CA2435729C (en) 2005-12-13
HK1058312A1 (en) 2004-05-14
ES2233876T3 (es) 2005-06-16
DK1355633T3 (da) 2005-04-04
HUP0303886A3 (en) 2005-05-30
NZ526926A (en) 2006-02-24
CA2435729A1 (en) 2003-06-26
EP1355633A1 (de) 2003-10-29
CN1503663A (zh) 2004-06-09
DE60202662T2 (de) 2006-01-05
US6827947B2 (en) 2004-12-07
NO20033653L (no) 2003-10-10

Similar Documents

Publication Publication Date Title
DE60202662D1 (de) NEUE FILMBESCHICHTUNG enthaltend ein Äthylacrylate/Methylmethacrylate-copolymer und Polyvinylacetat
NZ526792A (en) Film coating composition for controlled release from pharmaceutical formulations
ATE136576T1 (de) Durch wasser inaktivierbarer, druckempfindlicher klebstoff
KR910011242A (ko) 서방성 약학제제 및 그의 제조방법
JP2020524716A5 (de)
EA200601468A1 (ru) Частицы
ATE423179T1 (de) Amphiphile copolymerzusammensetzungen
GB1296241A (de)
RU2005108417A (ru) Двухкомпонентный клей с повышенной тепловой устойчивостью и продолжительным сроком хранения
DK1169032T3 (da) Ketoprofen-mikrogranuler, fremgangsmåde til fremstilling deraf og farmaceutiske præparater
DK1636318T3 (da) Opsvulmende overtrækssammensætninger
DK0999736T3 (da) Aftagelig beskyttelsesbelægning
WO2003070833A3 (en) Radiation curable compositions containing copolymers of isobutylene and acrylic monomers
JP2005154531A5 (de)
EP1435370A4 (de) Beschichtungsmaterialzusammensetzung
SE0201110D0 (sv) New film coating
SE0202353D0 (sv) New film coating
SE0104327D0 (sv) New film coating
DE69100134D1 (de) Tetrapolymer aus acrylsaeure, n,n-dimethylacrylamid, n-tert.-butylacrylamid und methacrylsaeureethylester sowie ein nichthalogeniertes treibgas enthaltender aerosolhaarlack.
TW200512262A (en) Composition for optical sheet
JPS5792031A (en) Liquid for surface-treatment of polyvinyl alcohol film
JPS5488938A (en) Adhesive composition
FI885495A (fi) Belaeggningsmaterial haerdbara vid rumstemperatur.
JPS57198764A (en) Resin composition for coating compound
JPS57149335A (en) Prevention of ultraviolet deterioration of polycarbonate molded article

Legal Events

Date Code Title Description
8364 No opposition during term of opposition